Iliac Bone Perforation in a Patient on Hemodialysis

Amaç & Hipotez:We report severe bone resorption with iliac bone perforation and vascular calcification due to longstanding hyperparathyroidism in a 60-year-old male patient who had undergone hemodialysis for 16 years.

📊

Temel Bulgular & Veri:Computed tomography images were obtained following a complicated hemodialysis catheterization of the femoral vein, and unprecedented bone findings were observed.

💡

Sonuç & Katkı:Improper management of chronic kidney disease–mineral bone disorder can lead to severe consequences, as observed in the present patient.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

We report severe bone resorption with iliac bone perforation and vascular calcification due to longstanding hyperparathyroidism in a 60-year-old male patient who had undergone hemodialysis for 16 years. Computed tomography images were obtained following a complicated hemodialysis catheterization of the femoral vein, and unprecedented bone findings were observed. Improper management of chronic kidney disease–mineral bone disorder can lead to severe consequences, as observed in the present patient.

🔖

Bu Makaleye Atıf Yap

SEVİNÇ, M., ŞAHUTOĞLU, E., SAKACI, T., ŞAHUTOĞLU, T. (2020). Iliac Bone Perforation in a Patient on Hemodialysis. Turkish journal of nephrology (Online), Cilt: 29 - Sayı: 1, 96–98. https://ajindex.com/articles/374839

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

Moorthi RN, Moe SM. CKD-mineral and bone disorder: core curriculum 2011. Am J Kidney Dis 2011; 58: 1022-36. [CrossRef] 2. Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int 2017; 92: 26-36. [CrossRef] 3. Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26: 1948-55. [CrossRef] 4. Bover J, Cozzolino M. Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation. Kidney Int Suppl 2011; 1: 122-9. [CrossRef] 5. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1-201. [CrossRef] 6. Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, et al. Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg 2012; 214: 400-7; discussion 407-8. [CrossRef] 7. Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, Jadav PR, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int 2004; 66: 2010-6. [CrossRef] 8. Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 2015; 88: 350-9. [CrossRef] 9. Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B. Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 2007; 18: 2401-7. [CrossRef] 10. Abdelhadi M, Nordenström J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 1998; 83: 3845-51. [CrossRef] 11. Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, et al. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 2015; 10: 90-7. [CrossRef] 12. Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Ann Intern Med 2018; 168: 422-30. [CrossRef]